document.write('

'); document.write('

ClinicalTrials.gov: Atrial fibrillation | updated in the last 30 days

'); document.write('

Clinical Evaluation of Therapy™ Cool Flex Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Condition: Paroxysmal Atrial Fibrillation
Intervention: Device: Therapy™ Cool Flex Ablation Catheter
Sponsor: St. Jude Medical
Recruiting - verified August 2010
Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease Conditions: Acute Coronary Syndrome; Coronary Artery Disease
Intervention: Drug: Atorvastatin
Sponsors: San Filippo Neri General Hospital; Associazione Nazionale Medici Cardiologi Ospedalieri, Sezione Lazio
Terminated - verified May 2010
Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF Condition: Atrial Fibrillation
Intervention: Procedure: Ablation of atrial fibrillation
Sponsors: Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de la Recherche Médicale, France
Active, not recruiting - verified March 2010
Sodium Channel Splicing in Heart Failure Trial Conditions: Atrial Fibrillation; Atrial Flutter; Heart Failure
Intervention:
Sponsors: University of Illinois; Jesse Brown Veterans Affairs Medical Center
Recruiting - verified August 2010
Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy Conditions: Atrial Fibrillation; Stroke
Interventions: Device: WATCHMAN Device; Drug: Warfarin
Sponsor: Atritech
Not yet recruiting - verified August 2010
SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI Condition: Atrial Fibrillation
Intervention: Drug: dronedarone
Sponsors: University of Utah; Sanofi-Aventis
Enrolling by invitation - verified August 2010
Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left Atrium Condition: Atrial Fibrillation
Intervention:
Sponsors: University of Utah; Biosense Webster, Inc.
Enrolling by invitation - verified August 2010
Spanish Atrial Fibrillation And Resynchronization Study Conditions: Chronic Heart Failure; Cardiomyopathy, Dilated; Atrial Fibrillation
Interventions: Procedure: Atrio ventricular junction ablation with radio-frequency; Drug: Beta blocker/digoxine/amiodarone
Sponsors: Hospital Clinic of Barcelona; University of Navarrra Hospital (Clinica Universitaria); Fundación para la Investigación del Hospital Clínico de Valencia; Puerta de Hierro University Hospital; Hospital Universitario Ramon y Cajal; Hospital Universitario La Fe; Hospital Universitario La Paz; Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Not yet recruiting - verified August 2010
Left Atrial Distensibility to Predict Prognosis in Consecutive Patients Conditions: Heart Failure; Atrial Fibrillation; Stroke
Intervention: Other: Echocardiography, including the measurements of left atrial (LA) distensibility
Sponsor: Kaohsiung Veterans General Hospital.
Recruiting - verified July 2009
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Condition: Atrial Fibrillation
Intervention: Other: Patients with Atrial Fibrillation (AF)
Sponsors: Ortho-McNeil Janssen Scientific Affairs, LLC; Duke University
Not yet recruiting - verified August 2010
Measurement of Left and Right Atria From CT Scans of Cardiac Rhythm Disorder Cases Condition: Atrial Fibrillation
Intervention: Other: There is no intervention that is a part of this study.
Sponsor: Kardium Inc.
Not yet recruiting - verified September 2010
Medical Versus Surgical Management of Moderate Mitral Regurgitation Following Percutaneous Coronary Intervention Conditions: Myocardial Infarction; Mitral Regurgitation
Intervention: Procedure: surgical mitral valve repair w/ mitral valve annuloplasty
Sponsor: Southern Illinois University
Recruiting - verified August 2010
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy Condition: Atrial Fibrillation
Interventions: Drug: Dronedarone (SR33589); Drug: placebo
Sponsor: Sanofi-Aventis
Recruiting - verified September 2010
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction Condition: Myocardial Infarction
Interventions: Drug: Eplerenone; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified September 2010
Atrial Fibrillation/Flutter Outcome Risk Determination Conditions: Atrial Fibrillation; Atrial Flutter
Intervention:
Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2010
International Registry on Cardioversion of Atrial Fibrillation Condition: Atrial Fibrillation
Intervention:
Sponsors: Merck; Institut für Herzinfarktforschung an der Universität Heidelberg
Recruiting - verified August 2010
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure Condition: Heart Failure
Interventions: Drug: Eplerenone; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified September 2010
Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation Condition: Symptomatic Paroxysmal Atrial Fibrillation
Intervention: Procedure: Arctic Front® catheter vs. HD Mesh Ablator® catheter
Sponsors: Charite University, Berlin, Germany; German Federal Ministry of Education and Research
Recruiting - verified August 2010
Irrigated Ablation System Evaluation for AF Condition: Paroxysmal Atrial Fibrillation
Interventions: Device: SJM Irrigated Cardiac Ablation System; Device: FDA approved Open Irrigated RF Ablation System
Sponsor: St. Jude Medical
Enrolling by invitation - verified March 2010
Safer Warfarin Treatment Conditions: Atrial Fibrillation; Venous Thrombosis; Pulmonary Embolism; Heart Valve Prosthesis
Intervention: Other: Blood specimens (whole blood, serum, plasma)
Sponsors: Oslo University Hospital; Norway: University of Oslo; Norway: Norwegian Medicines Agency; Norway: South-Eastern Norway Regional Health Authority
Recruiting - verified July 2010
Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia Conditions: Atrial Fibrillation; Ischemic Ventricular Tachycardia
Intervention: Device: Radiofrequency Catheter Ablation
Sponsor: Biosense Webster, Inc.
Active, not recruiting - verified August 2010
Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA) Condition: Atrial Fibrillation
Interventions: Drug: DRONEDARONE; Drug: PLACEBO DRONEDARONE
Sponsor: Sanofi-Aventis
Recruiting - verified August 2010
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Condition: Persistent Atrial Fibrillation
Interventions: Drug: Ibutilide; Drug: Placebo
Sponsors: Mount Sinai School of Medicine; St. Jude Medical
Recruiting - verified August 2010
The RECORD Asia-Pacific Atrial Fibrillation Registry Condition: Atrial Fibrillation
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified August 2010
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System Condition: Venous Thromboembolism
Intervention: Device: vMetrics - Anticoagulation Management System device
Sponsors: ZIN Technologies, Inc.; The Cleveland Clinic
Completed - verified September 2010
Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: beta blockers; Drug: amiodarone; Drug: ascorbic acid
Sponsor: Maine Medical Center
Recruiting - verified August 2010
Optimize RV Follow-up Selective Site Pacing Clinical Trial Conditions: Cardiac Pacing, Artificial; Cardiac Pacemaker, Artificial
Interventions: Device: Medtronic or Vitatron Dual-Chamber Pacemaker; Device: Medtronic SelectSecure 3830 Lead
Sponsor: Medtronic Cardiac Rhythm Disease Management
Enrolling by invitation - verified August 2010
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke Conditions: Cryptogenic Symptomatic Transient Ischemic Attack; Cryptogenic Ischemic Stroke
Intervention: Device: Reveal® XT Insertable Cardiac Monitor
Sponsors: Medtronic Cardiac Rhythm Disease Management; Medtronic Bakken Research Center
Recruiting - verified August 2010
Genotype-Guided Warfarin Therapy Trial Conditions: Atrial Fibrillation; Deep Vein Thrombosis; Pulmonary Embolism; Artificial Heart Valve
Interventions: Other: Genotype-guided dose determination; Other: Non-genotype guided warfarin dosing
Sponsors: University of North Carolina, Chapel Hill; UNC Institute for Pharmacogenomics and Individualized Therapy
Recruiting - verified August 2010
Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation Conditions: Atrial Fibrillation; Catheter Ablation
Interventions: Procedure: Additional Complex Fractionated Electrograms ablation; Procedure: Standard atrial fibrillation ablation procedure
Sponsors: Hospital Clinic of Barcelona; Fundacio Clinic
Recruiting - verified August 2010
Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation Condition: Atrial Fibrillation
Interventions: Procedure: Atrial fibrillation ablation; Drug: Antiarrhythmic drug
Sponsors: Hospital Clinic of Barcelona; Medtronic; Fundacio Clinic; Biosense Webster, Inc.
Recruiting - verified August 2010
ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology Condition: Atrial Fibrillation
Intervention: Device: WATCHMAN
Sponsor: Atritech
Recruiting - verified August 2010
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event Conditions: Stroke; Transient Ischemic Attack; Atrial Fibrillation; Atrial Flutter
Interventions: Device: a 30-day ambulatory cardiac event monitor; Device: 24-hour Holter
Sponsor: Sunnybrook Health Sciences Centre
Recruiting - verified September 2010
Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery Conditions: Cardiac Surgery; Atrial Fibrillation; Post-Operative Delirium
Interventions: Drug: Lidocaine; Drug: Lidocaine; Other: Placebo
Sponsor: Outcomes Research Consortium
Recruiting - verified August 2010
The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation Condition: Atrial Fibrillation
Interventions: Procedure: Catheter ablation; Drug: Amiodarone; Drug: Placebo
Sponsor: Rigshospitalet, Denmark
Recruiting - verified August 2010
The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery Condition: Atrial Fibrillation
Intervention:
Sponsor: University of Illinois
Recruiting - verified August 2010
Effect of Balloon Cryoablation on Left Atrial Function Condition: Atrial Fibrillation
Intervention: Device: Pulmonary vein isolation with cryoballoon catheter
Sponsor: Reddy, Vivek Y., M.D.
Recruiting - verified August 2010
Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation Condition: Atrial Fibrillation
Intervention:
Sponsor: Creighton University
Recruiting - verified August 2010
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial Condition: Atrial Fibrillation
Interventions: Drug: dabigatran dose 2; Drug: dabigatran dose 2; Drug: dabigatran dose 1
Sponsor: Boehringer Ingelheim Pharmaceuticals
Active, not recruiting - verified August 2010
Corticosteroid Pulse After Ablation Condition: Atrial Fibrillation
Interventions: Drug: Solumedrol; Drug: Placebo
Sponsors: Minneapolis Heart Institute Foundation; St Jude Medical (grant)
Active, not recruiting - verified August 2010
Study of New Implantable Loop Recorder Conditions: Tachyarrhythmias; Syncope
Intervention: Device: SJM Confirm
Sponsor: St. Jude Medical
Recruiting - verified August 2010
Implantable Loop Recorder Versus Conventional Ambulatory Monitoring in Detecting Atrial Fibrillation After Pulmonary Vein Isolation Condition: Atrial Fibrillation
Intervention: Device: Implantable loop recorder (ILR)
Sponsor: Odense University Hospital
Recruiting - verified August 2010
Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation Condition: Atrial Fibrillation
Intervention: Procedure: Endoscopy in group I (all patients)
Sponsor: University of Oklahoma
Recruiting - verified August 2010
Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study Condition: Atherosclerosis
Intervention: Procedure: transthoracic examination
Sponsor: Creighton University
Recruiting - verified August 2010
CONcomitant eValuation of Epicor Left atRial Therapy for AF Condition: Atrial Fibrillation
Interventions: Device: Epicor LP Cardiac Ablation System; Procedure: Surgical ablation of permanent AF
Sponsor: St. Jude Medical
Enrolling by invitation - verified August 2010
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation Conditions: Atrial Fibrillation; Thromboembolism
Interventions: Drug: Edoxaban (DU-176b); Drug: Edoxaban (DU-176b); Drug: Edoxaban (DU-176b); Drug: Edoxaban (DU-176b); Drug: warfarin
Sponsor: Daiichi Sankyo Inc.
Completed - verified September 2010
A Phase III Study of Apixaban in Patients With Atrial Fibrillation Condition: Atrial Fibrillation
Interventions: Drug: Apixaban; Drug: Acetylsalicylic Acid (ASA); Drug: Apixaban
Sponsors: Bristol-Myers Squibb; Pfizer
Active, not recruiting - verified August 2010
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: warfarin; Drug: apixaban
Sponsor: Bristol-Myers Squibb
Active, not recruiting - verified June 2010
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation Conditions: Fibrillation, Atrial; Atrial Fibrillation
Interventions: Drug: omega-3-acid ethyl esters; Drug: Placebo
Sponsor: GlaxoSmithKline
Completed - verified August 2010
Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation Condition: Atrial Fibrillation
Interventions: Procedure: Catheter ablation; Procedure: Thoracoscopic epicardial ablation
Sponsor: Rigshospitalet, Denmark
Terminated - verified July 2007
Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT) Conditions: Atrial Fibrillation; Tachycardia, Supraventricular; Arrhythmia; Bradycardia
Intervention: Device: Implantable Pulse Generator
Sponsor: Medtronic Cardiac Rhythm Disease Management
Active, not recruiting - verified September 2010
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Conditions: Atrial Fibrillation; Cerebrovascular Accident
Interventions: Drug: Dabigatran etex; Drug: Warfarin
Sponsor: Boehringer Ingelheim Pharmaceuticals
Completed - verified September 2010
Atrial Fibrillation Feasibility Certoparin Trial - AFFECT Condition: Persistent Nonvalvular Atrial Fibrillation
Intervention: Drug: Certoparin
Sponsor: Novartis
Completed - verified March 2008
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 Conditions: Atrial Fibrillation; Cerebrovascular Accident
Intervention: Drug: Dabigatran etexilate
Sponsor: Boehringer Ingelheim Pharmaceuticals
Terminated - verified August 2010

'); document.write('

');